|
[1]YANG FN, HUANG J.Research progress in genetic susceptibility to alcoholic liver disease[J].J Clin Hepatol, 2017, 33 (2) :379-383. (in Chinese) 杨馥宁, 黄晶.酒精性肝病的遗传易感性研究现状[J].临床肝胆病杂志, 2017, 33 (2) :379-383.
|
|
[2]LIN XX, CHEN D, ZHAO Q, et al.Genetic research on the incidence of alcoholic liver disease[J].Chin J Clin Pharmacol Ther, 2017, 22 (11) :1309-1314. (in Chinese) 林秀贤, 陈丹, 赵青, 等.影响酒精性肝病发病的遗传学研究进展[J].中国临床药理学与治疗学, 2017, 22 (11) :1309-1314.
|
|
[3]WANG HY, LI X, XU YQ.Progress in the pathogenesis of alcoholic liver disease[J].J Pract Hepatol, 2014, 17 (1) :5-8. (in Chinese) 王洪岩, 李鑫, 徐有青.酒精性肝病发病机制研究进展[J].实用肝脏病杂志, 2014, 17 (1) :5-8.
|
|
[4]LU XL, TAO M, LUO JY.Epidemiology of alcoholic liver diseases in Xi'an[J].World Chin J Dig, 2003, 11 (6) :719-722. (in Chinese) 鲁晓岚, 陶明, 罗金燕.西安酒精性肝病流行病学[J].世界华人消化杂志, 2003, 11 (6) :719-722.
|
|
[5]HUANG SL, DAI SQ, ZHANG XH, et al.An epldemlologlcal survey of alcoholic liver disease in Hunan province[J].Chin JPhysician, 2005, 7 (3) :426-427. (in Chinese) 黄顺玲, 戴水奇, 张雪红, 等.湖南省酒精性肝病流行病学调查慨况[J].中国医师杂志, 2005, 7 (3) :426-427.
|
|
[6]PALUMBO A, ANDERSON K.Multiple myeloma[J].N Engl JMed, 2011, 364 (11) :1046-1060.
|
|
[7]SCHWARTZ JM, REINUS JF.Prevalence and natural history of alcoholic liver disease[J].Clin Liver Dis, 2012, 16 (4) :659-666.
|
|
[8]ASRANI SK, KAMATH PS, PEDERSEN R, et al.Liver related mortality in the US is underestimated[J].Hepatology, 2010, 52:408A.
|
|
[9]HAO W, CHEN CH, SU Z.China:Alcohol today[J].Addiction, 2005, 100 (6) :737-741.
|
|
[10]National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association;Fatty Liver Expert Committee, Chinese Medical Doctor Association.Guidelines of prevention and treatment for alcoholic liver disease:A 2018 update[J].J Clin Hepatol, 2018, 34 (5) :939-946. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会.酒精性肝病防治指南 (2018年更新版) [J].临床肝胆病杂志, 2018, 34 (5) :939-946.
|
|
[11]GAO B, BATALLER R.Alcoholic liver disease:Pathogenesis and new therapeutic targets[J].Gastroenterology, 2011, 141 (5) :1572-1585.
|
|
[12]XIONG AH.Diagnosis and treatment of alcoholic liver disease[J].Chin J Clin Ration Drug Use, 2013, 5 (36) :88. (in Chinese) 熊爱辉.酒精性肝病的诊治分析[J].临床合理用药杂志, 2013, 5 (36) :88.
|
|
[13] Chinese Hematology Association, Chinese Society of Hematology, Chinese Myeloma Committee-Chinese Hematology Association.The guidelines for the diagnosis and management of multiple myeloma in China (2015 revision) [J].Chin J Inter Med, 2015, 54 (12) :1066-1070. (in Chinese) 中国医师协会血液科医师分会, 中华医学会血液学分会, 中国医师协会多发性骨髓瘤专业委员会.中国多发性骨髓瘤诊治指南 (2015年修订) [J].中华内科杂志, 2015, 54 (12) :1066-1070.
|
|
[14]MA LJ, LI LJ, ZHANG LS.Current status and prospects of the treatment of multiple myeloma[J].Clin Focus, 2015, 30 (4) :476-480. (in Chinese) 马李洁, 李莉娟, 张连生.多发性骨髓瘤治疗现状及前景[J].临床荟萃, 2015, 30 (4) :476-480.
|
|
[15]WU HB, ZHANG G, HAN B, et al.Clinical features and risk factors for infecfions in multiple myeloma during chemotherapy[J].Chin J Clin Pharmacol Ther, 2018, 23 (1) :93-98. (in Chinese) 吴海兵, 张刚, 韩彬, 等.多发性骨髓瘤患者住院化疗感染的临床特征及影响因素研究[J].中国临床药理学与治疗学, 2018, 23 (1) :93-98.
|
|
[16]SUN XJ, ZHAGN CH, WANG Q.Research advances in the treatment of multiple myeloma[J].J Continuing Med Education, 2018, 32 (4) :107-109. (in Chinese) 孙雪娇, 张翠红, 王谦.多发性骨髓瘤治疗进展[J].继续医学教育, 2018, 32 (4) :107-109.
|
|
[17]ZHOU JY, WANG J, TANG H.An analysis of misdiagnosis data of multiple myeloma[J].Int J Lab Med, 2016, 37 (10) :1396-1398. (in Chinese) 周靖泳, 王娟, 汤华.多发性骨髓瘤误诊资料分析[J].国际检验医学杂志, 2016, 37 (10) :1396-1398.
|
|
[18]XIE YH, LIU LG, GAO W, et al.Multiple myeloma with jaundice as the initial manifestation:A case report[J].Diagn Concepts Pract, 2006, 5 (1) :68-69. (in Chinese) 谢英华, 刘立根, 高武, 等.以黄疸为首发表现的多发性骨髓瘤一例[J].诊断学理论与实践, 2006, 5 (1) :68-69.
|
DownLoad: